Lynn Kirkpatrick is the founder of Ensysce Biosciences. Ensysce Biosciences has raised $60M in total funding. Based in La Jolla, California.
Dr. Lynn Kirkpatrick is the CEO of Ensysce Biosciences, a clinical-stage pharmaceutical company focused on developing novel medicines to reduce prescription opioid misuse and addiction. She became president and CEO in January 2009 and has led the company to secure over $60 million in funding.
Full founder directory · Investor directory · Company funding database · Fundraising library